Steroid hormones and cancer: (II) lessons from experimental systems

European Journal of Surgical Oncology

Volumn 23, Issue 1, 1997, Pages 72-83

  Miller, W R ^a   Langdon, S P ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Cell lines; Endometrial cancer; Growth factors; Ovarian cancer; Steroid hormones; Steroid receptors; Xenografts

Indexed keywords

STEROID HORMONE;

BREAST CANCER; ENDOMETRIUM CANCER; OVARY CANCER; PRIORITY JOURNAL; REVIEW;

EID: 0031027731     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(97)80148-5     Document Type: Article

References (26)

1. Soule HD, Vazguez J, Long A, Albert S, Brennan M. Human cell line from a pleural effusion derived from a human breast carcinoma. J Natl Cancer Inst 1973; 51: 1409-16.
2. Engel LW, Young NA, Tralka TS, Lippman ME, O'Brien SJ, Joyce MJ. Establishment and characterisation of three new continuous cell lines derived from human breast carcinomas. Cancer Res 1978; 38: 3352-64.
3. Keydar I, Chen L, Karyby S, et al. Establishment and characterisation of a cell line of human breast carcinoma origin. Eur J Cancer 1979; 15: 659-70.
4. Whitehead RH, Quirk SJ, Vitali AA, Funder JW, Sutherland RL, Murphy LC. A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness. J Natl Cancer Inst 1984; 73: 643-8.
5. Leung BS, Qureshi S, Leung JS. Response to estrogen by the human mammary carcinoma cell line CAMA-1. Cancer Res 1982; 42: 5060-6.
6. Reiner GCA, Katzenellenbogen BS. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells. Cancer Res 1986; 46: 1124-31.
7. Engel LW, Young NW. Human breast carcinoma cells in continuous culture: a review. Cancer Res 1978; 38: 4327-39.
8. van Slooten HJ, Bonsing BA, Hiller AJ, Colbern GT, van Dierendonck JH, Cornelisse CJ, Smith HS. Outgrowth of BT0474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer. Br J Cancer 1995; 72: 22-300.
9. Brunner N, Spang-Thomsen M, Cullen K. The T61 human breast cancer xenograft - an experimental model of estrogen therapy of breast cancer. Breast Cancer Res Treat 1996; 39: 87-92.
10. Clarke R. Human breast cancer cell line xenografts as models of breast cancer - the immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines. Breast Cancer Res Treat 1996; 39: 69-86.
11. Lippman ME, Monaco ME, Bolan G. Effects of estrone, estradiol and estriol on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 1977; 37: 1901-7.
12. Soule HD, McGrath CM. Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice. Cancer Lett 1980; 10: 177-89.
13. Levenson AS, Jordan VC. Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines. J Steroid Biochem Mol Biol 1994; 51: 229-39.
14. Ikeda T, Danielpour D, Sirbasku DA. Isolation and properties of endocrine and autocrine type mammary tumor cell growth factors (estromedins). In: Bresciani F, King RJB, Lippman ME et al, (eds) Progress in Cancer Research and Therapy, Vol. 31, New York: Raven Press, 1983: 171-186.
15. Dickson RB, Lippman ME. Estrogen regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrim Rev 1986; 8: 29-43.
16. Salomon DS, Kidwell WR, Kim N, et al. Modulation by estrogen and growth factor of transforming growth factor alpha (TGF-α) expression in normal and malignant human mammary epithelial cells. Recent Res Cancer Res 1989; 113: 57-69.
17. Lippman ME, Dickson RB. Growth control of normal and malignant breast epithelium. Proc Roy Soc Edin 1989; 95B: 89-106.
18. Huff KK, Knabbe C, Lindsey R, Kaufman D, Bronzert D, Lippman ME, Dickson RB. Multihormonal regulation of insulin-like growth factor-1-related protein in MCF-7 human breast cancer cells. Mol Endocrinol 1988; 2: 200-8.
19. Brunner N, Yee D, Kern FG, Spang-Thomsen M, Lippman ME, Cullen KJ. Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor-II (IGF-II). Eur J Cancer 1993; 29: 562-9.
20. McCotter D, van den Berg, HW, Boylan M, McKibben B. Changes in insulin-like growth factor-I receptor expression and binding protein secretion associated with tamoxifen resistance and estrogen independence in human breast cancer cells in vitro. Cancer Letts 1996; 99: 239-45.
21. Bronzert DA, Pantazis P, Antoniades HN, Kasid A, Davidson N, Dickson RB, Lippman ME. Synthesis and secretion of PDGF-like growth factor by human breast cancer cell lines. Proc Natl Acad Sci USA 1987; 84: 5763-5767.
22. Yarden Y, Escobedo JA, Kuang WJ, Yang-Feng TL, Daniel TO, Tremble PM, Chen EY, Ando ME, Harkins RN, Francke U. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factors. Nature 1986; 323: 226-32.
23. Clemmons DR, Shaw DS. Variables controlling somatomedin production by cultured human fibroblasts. J Cell Physiol 1983; 115: 137-42.
24. Roberts AB, Sporn MB. The transforming growth factor-β. In: Sporn MB, Roberts AB (eds) Handbook of Experimental Pharmacology, Vol. 95. Heidelberg: Springer-Verlag, 1990; 419-72.
25. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB. Evidence that TGF-beta is a hormonally regulated growth factor in human breast cancer cells. Cell 1987; 48: 417-28.
26. Arteaga CL, Tandon AAK, Von Hoff DD, Osborne CK. Transforming growth factor β: potential autocrine growth inhibitor of estrogen receptor negative human breast cancer cells. Cancer Res 1988; 48: 3898-904.